Trial intelligence / Profile preview

Biapenem vs imipenem/cilastatin in acute bacterial respiratory or urinary infections

CTR20132143Phase 2Active

Sponsor
Tianjin Pharmaceutical Group Technology Development
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of biapenem in bacterial airway infections, urinary tract infection (UTI), sponsored by Tianjin Pharmaceutical Group Technology Development. Started Aug 2014; status: active.

02

Drugs

biapenem
03

Conditions

bacterial airway infectionsurinary tract infection (UTI)

Beyond the preview

Go deeper on CTR20132143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call